BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15149320)

  • 21. Role of renocortical cyclooxygenase-2 for renal vascular resistance and macula densa control of renin secretion.
    Castrop H; Schweda F; Schumacher K; Wolf K; Kurtz A
    J Am Soc Nephrol; 2001 May; 12(5):867-874. PubMed ID: 11316844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics.
    Harding P; Carretero OA; Beierwaltes WH
    J Hypertens; 2000 Aug; 18(8):1107-13. PubMed ID: 10954003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys.
    Matzdorf C; Kurtz A; Höcherl K
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1782-90. PubMed ID: 17376760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-2 inhibition attenuates lipopolysaccharide-induced cardiovascular failure.
    Höcherl K; Dreher F; Kurtz A; Bucher M
    Hypertension; 2002 Dec; 40(6):947-53. PubMed ID: 12468584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of renin and Cox-2 expression in the renal cortex of C57Bl/6 mice.
    Wagner C; Vitzthum H; Castrop H; Schumacher K; Bucher M; Albertin S; Coffman TM; Arendshorst WJ; Kurtz A
    Pflugers Arch; 2003 Nov; 447(2):214-22. PubMed ID: 14504926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension.
    Wang JL; Cheng HF; Harris RC
    Hypertension; 1999 Jul; 34(1):96-101. PubMed ID: 10406830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Reinalter SC; Jeck N; Brochhausen C; Watzer B; Nüsing RM; Seyberth HW; Kömhoff M
    Kidney Int; 2002 Jul; 62(1):253-60. PubMed ID: 12081585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase-2 contributes to elevated renin in the early postnatal period in rats.
    Stubbe J; Jensen BL; Bachmann S; Morsing P; Skøtt O
    Am J Physiol Regul Integr Comp Physiol; 2003 May; 284(5):R1179-89. PubMed ID: 12560203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney.
    Höcherl K; Dreher F; Vitzthum H; Köhler J; Kurtz A
    J Am Soc Nephrol; 2002 Oct; 13(10):2427-36. PubMed ID: 12239231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2 inhibitors attenuate increased blood pressure in renovascular hypertensive models, but not in deoxycorticosterone-salt hypertension.
    Okumura T; Hayashi I; Ikezawa T; Yamanaka M; Takata T; Fujita Y; Saigenji K; Yamashina S; Majima M
    Hypertens Res; 2002 Nov; 25(6):927-38. PubMed ID: 12484518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
    J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal protective effects of specific cyclooxygenase-2 inhibitor in rats with subtotal renal ablation].
    Kong WX; Ma J; Gu Y; Yang HC; Zuo YQ; Lin SY
    Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):186-90. PubMed ID: 12816702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Everolimus treatment downregulates renocortical cyclooxygenase-2 expression in the rat kidney.
    Höcherl K; Hensel C; Ulbricht B; Krämer BK
    Br J Pharmacol; 2005 Aug; 145(8):1112-22. PubMed ID: 15937522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of renal nerves in stimulation of renin, COX-2, and nNOS in rat renal cortex during salt deficiency.
    Höcherl K; Kammerl M; Kees F; Krämer BK; Grobecker HF; Kurtz A
    Am J Physiol Renal Physiol; 2002 Mar; 282(3):F478-84. PubMed ID: 11832429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase 2 and neuronal nitric oxide synthase expression in the renal cortex are not interdependent in states of salt deficiency.
    Castrop H; Kammerl M; Mann B; Jensen BL; Krämer BK; Kurtz A
    Pflugers Arch; 2000 Dec; 441(2-3):235-40. PubMed ID: 11211108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.
    Swan SK; Rudy DW; Lasseter KC; Ryan CF; Buechel KL; Lambrecht LJ; Pinto MB; Dilzer SC; Obrda O; Sundblad KJ; Gumbs CP; Ebel DL; Quan H; Larson PJ; Schwartz JI; Musliner TA; Gertz BJ; Brater DC; Yao SL
    Ann Intern Med; 2000 Jul; 133(1):1-9. PubMed ID: 10877734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism.
    Klein T; Neuhaus K; Reutter F; Nüsing RM
    Br J Pharmacol; 2001 Jul; 133(5):643-50. PubMed ID: 11429387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.